Consortium Oliver (oligo-liver-metastases)

News (14/02/2023) 

The annual meeting of the OLiver (oligo-liver-metastases) consortium was held at the Jules Bordet Institute on Wednesday 18 January 2023, with some 50 people present. The active and fruitful debate highlighted new results and identified new avenues for research. Recent progress includes the launch of a new project aiming to arrive at a better understanding of the cellular and molecular mechanisms involved in metastatic progression with reference to a model of liver metastases in mice. (Headed by Professor Etienne Meylan, the IMI and CMMI, Gosselies-ULB and various H.U.B. clinical teams are cooperating on this project). 

The main aims of the OLiver project are to study oligometastatic disease, seek predictive markers and better understand the fundamental mechanisms involved in this type of progression in a cancerous disease. Clinicians from various specialities (oncology, anatomical pathology, medical imaging, nuclear medicine, radiotherapy, surgery) as well as researchers from a number of laboratories (immunology, anatomical pathology, biology) are all active within this consortium. The implementation of translational projects is favoured by an interdisciplinary and inter-university (ULB, KU Leuven, UZ Antwerp, UCL, VUB) dialogue and by the close links between the various teams in Europe, especially in the Netherlands and France.